期刊文献+

慢病毒介导shRNA沉默STAT3表达治疗结直肠癌的体内外研究 被引量:2

Effect of signal transducers and activators of transcription 3 gene silencing by shRNA mediated by lentiviral vector for the treatment of colorectal cancer
原文传递
导出
摘要 目的 探讨慢病毒介导shRNA沉默STAT3表达对结直肠癌生长的影响.方法 分别用慢病毒干扰质粒pRNAT-shSTAT3、慢病毒空质粒pRNAT-GFP和慢病毒包装质粒混合物共转染293T细胞,获得慢病毒分别感染结直肠癌HT-29细胞,筛选培养后获得HT-29-shSTAT3、HT-29-GFP细胞株.将3种细胞株用于建立裸鼠皮下移植瘤模型,分为3组:第1组为HT-29组,第2组为HT-29-GFP组,第3组为HT-29-shSTAT3组,每组5只.MTT法检测细胞生长情况,流式细胞仪检测细胞周期变化,取瘤组织切片行CD34免疫组织化学观察肿瘤微血管密度(MVD)的变化.应用单因素方差分析检测结果.结果 结直肠癌HT-29、HT-29-GFP细胞株生长能力明显强于HT-29-shSTAT3细胞株,3者比较,差异有统计学意义(F=632.50,P〈0.05).HT-29-shSTAT3细胞株生长明显减慢,G0/G1期细胞占68.7%±2.9%,HT-29-GFP细胞株为38.5%±1.6%,HT-29细胞株为38.7%±2.3%;3者比较,差异有统计学意义(F=166.53,P〈0.05).HT-29组、HT-29-GFP组和HT-29-sh STAT3组MVD分别为29±5、28±4、10±3,3组比较,差异有统计学意义(F=31.60,P〈0.05).结论 慢病毒介导的shRNA沉默STAT3表达能明显抑制结直肠癌的生长. Objective To determine the effect of signal transducers and activators of transcription 3 (STAT3) gene silencing by shRNA mediated by lentiviral vector for the treatment of colorectal cancer. Methods The recombinant lentiviral vector pRNAT-shSTAT3, empty lentiviral vector pRNAT-GFP, and lentiviral packaging plasmids in supernatant were collected to transfect HT-29 cells for harvesting the HT-29-shSTAT3 cells and HT29-GFP cells. Fifteen male rats were divided into three groups (n = 5 ), and then they were inoculated with HT-29cells, HT-29-GFP cells and HT-29-shSTAT3 cells, respectively. Cell growth was assessed by MTT assay and the changes in cell cycle were detected by flow cytometry. The changes in microvessel density (MVD) of tumors were detected by immunohistochemistry. All data were analysed by one-way analysis of variance. Results The growth of HT-29-shSTAT3 cells was significantly suppressed compared with HT-29 and HT-29-GFP cells (F = 632.50,P 〈 0. 05 ). The proportions of cells at the G0/G1 phase were 68.7% ± 2.9% in HT-29-shSTAT3 cells, 38.5% ±1.6% in HT-29-GFP cells and 38.7% ± 2.3% in HT-29 cells, with a significant difference among the three groups (F = 166.53, P 〈 0.05 ). The MVDs of HT-29 cells, HT-29-GFP cells and HT-29-shSTAT3 cells were 29 ±5, 28 ±4 and 10 ±3, respectively, with a significant difference among the three groups (F=31.60, P 〈0.05). Conclusion STAT3 gene silencing by shRNA mediated by lentiviral vector can significantly inhibit the growth of colorectal cancer cells.
出处 《中华消化外科杂志》 CAS CSCD 2010年第4期269-272,共4页 Chinese Journal of Digestive Surgery
基金 国家自然科学基金(30772242) 江苏省苏州社会发展基金(SS08033)
关键词 大肠肿瘤 RNA干扰 SHRNA 信号转导和转录激活子3 Colorectal neoplasms RNA interfering shRNA Signal transducers and activators of transcription 3
  • 相关文献

参考文献6

  • 1Kunnumakkara AB,Nair AS,Sung B,et al.Boswellic acid blocks signal transducers and activetors of transcription 3 signaling,proliferation,and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.Mol Cancer Res,2009,7 (1):118 -128.
  • 2Tsareva SA,Moriggl R,Corvinus FM,et al.Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix met alloproteinase induction.Neoplasia,2007,9 (4):279-291.
  • 3钱伟峰,管文贤,高源,乔志明,夏春林.大肠癌组织中STAT3的表达及其对肿瘤血管生成的影响[J].中国临床解剖学杂志,2009(3):310-312. 被引量:1
  • 4Kusaba T,Nakayama T,Yamazumi K,et al.Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma;correlation with clinicopathological factors.J Clin Pathol,2005,58(8):833 -838.
  • 5吕伟,张超,郝迎学,刘伟,余佩武.Stat3靶向RNA干扰重组体的构建及鉴定[J].消化外科,2006,5(4):283-287. 被引量:4
  • 6Hsieh FC,Cheng G,Lin J.Evaluation of potential Stat3-regulated genes in human breast cancer.Biochem Biophys Res Commun,2005,335 (2):292 -299.

二级参考文献11

  • 1Bao-He Zhu, Wen-Hua Zhan, Zheng-Rong Li, Zhao Wang, Yu-Long He, Jun-Sheng Peng, Shi-Rong Cai, Jin-Ping Ma, Chang-Hua Zhang, Department of Gastrointestinal & Pancreatic Surgery, First Affiliated Hospital, Sun Yat-Sen University,Gastric Center of Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis[J].World Journal of Gastroenterology,2007,13(8):1162-1169. 被引量:30
  • 2Buettner R,Mora L B,Jove R.Activated Stat signaling in human tumors provides novel molecular targets for therapeutic intervention[J].Clin Cancer Res,2002,8(4):945-954.
  • 3Mora L B,Buettner R,Seigne J,et al.Constitutive activation of Stat3 in human prostate tumors and cell lines:direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells[J].Cancer Res,2002,62(22):6659-6666.
  • 4Bowman T,Garcia R,Turkson J,et al.Stats in oncogenesis[J].Oncogene,2000,19(21):2474-2488.
  • 5Trovato M,Vitarelli E,Grosso M,et al.Immunohistochemical expression of HGF,c-MET and transcription factor Stat3 in colorectal tumors[J].Eur J Histochem,2004,48(3):291-298.
  • 6Fire A,Xu S,Montgomery M K,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Natrue,1998,391(6669):744-745.
  • 7Elbashir S M,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411(6836):494-498.
  • 8Ahmed-Choudhury J,Williams K T,Young L S,et al.CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of Stat3 in addition to activation of JNK1/2 and ERK1/2[J].Cell Signal,2006,18(4):456-468.
  • 9Wida M,Fuchs U,Wossmann W,et al.Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference(RNAi)[J].Oncogene,2002,21(37):5716-5724.
  • 10Paul C P,Good P D,Winer I,et al.Effective expdression of small interfering RNA in human cells[J].Nat Biotechnol,2002,20(5):505-508.

共引文献3

同被引文献28

  • 1Lewis B. A gene complex controlling segmentation in Dro- sophila[J]. Nature, 1978, 276(5688):565-570.
  • 2Sparmann A, Van Lohuizen M. Polycomb silencers control cell fate, development and cancer[J]. Nat Rev Cancer, 2006, 6(11):846-856.
  • 3Nunes M, Blanc I, Maes J, etal. NSPcl, a novelmamma-lian Polycomb gene, is expressed in neural crest-derived struc- tures of the peripheralnervous system[J]. Mech Dev, 2001, 102(1-2):219-222.
  • 4Sultmann H, Heydebreck A, Huber W, et al. Gene expression in kidney cancer is associated with cytogenetic abnormali- ties, metastasis formation, and patient survival[J]. Clin Can- cerRes, 2005, 11(2Ptl):646-655.
  • 5Laurent S, Boutry S, Mahieu I, et al. Iron oxide based MR contrast agents: from chemistry to cell labeling[J]. Curr Med Chem, 2009, 16(35):4712-4727.
  • 6Koh DM, Brown G, Collings DJ. Nanoparticles in rectal can- cer imaging[J]. Cancer Biomark, 2009, 5(2):89-98.
  • 7Vento TJ, Prakash V, Murry CK, et al. Pneumonia in nulitary trainess: a comparison study based on adenovirus serotype 14 infection[J]. J Infect Dis, 2011,203(10):1388-1395.
  • 8ElLis J. Silencing and variegation of gamma retrovirus and len- tivirus vectors[J]. Hum Gene Ther, 2005, 16(11): 1241-1246.
  • 9Dissen GA, Lomniczi A, Neff TL, et al. In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles[J]. Methods, 2009, 49(1):70-77.
  • 10Brenchley JM, Silvestri G, Douek DC. Nonprogessive and progressive primate immunodeficiency lentivirus infections [J]. Immunity, 2010, 32(6):737-742.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部